N
NeoGenomics, Inc.
NEO · NASDAQ · Healthcare · 410M
Closing price
$16.35
+2.06% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.5×
Enterprise value / EBITDAEV/EBITDA
-18.9×
Free cash flow yieldFCF yield
-5.2%
Return on equityROE
-12.9%
Operating margin
-9.1%
Net debt / EBITDAbalance-sheet strength
-8.1×
Interest coverage
-17.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.